- Regulus Therapeutics (NASDAQ:RGLS) -30% after FDA suspends enrollment in Phase 1 study of RGLS4326.
- More news on: Regulus Therapeutics Inc., Tupperware Brands Corporation, iRobot Corporation, Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CannTrust Holdings Inc. Company Name:
CTST Stock Symbol:
NYSE Market:
CannTrust Extends Time to Call Annual General Meeting Canada NewsWire VAUGHAN, ON , July 7, 2022 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company") (unlisted), today announced that the Ontario Superior Court of Justice granted an order ex...
CannTrust Applies to Ontario Court to Extend Time for Annual General Meeting and Provides Update Regarding Strategic Review Canada NewsWire VAUGHAN, ON , June 23, 2022 /CNW/ - CannTrust Holdings Inc. (the "Company" or "CannTrust") (unlisted), minority inv...
CannTrust Announces New Investment Partners, Provides Timeline for CCAA Exit Canada NewsWire VAUGHAN, ON , Feb. 25, 2022 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or the "Company") (unlisted) today announced that it has secured new investment partners, ...